About

Additional Languages

Spanish

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Mycophenolate mofetil use is associated with reduced incidence of food allergy in liver transplanted children. Ley, SL; Kidwell, KM; Van Dyk, TR; Orkin, S; Odar Stough, C; Howarth, T; Goetz, AR; Xanthakos, SA; Bramlage, K; Mouzaki, M; et al. Journal of Pediatric Gastroenterology and Nutrition. 2022; 75:138-144.

Clinically Meaningful Body Mass Index Change Impacts Pediatric Nonalcoholic Fatty Liver Disease. Khurana, T; Klepper, C; Fei, L; Sun, Q; Bramlage, K; Arce-Clachar, AC; Xanthakos, S; Mouzaki, M. Journal of Pediatrics. 2022.

Insight Into the Adolescent Patient Experience With Nonalcoholic Fatty Liver Disease. Ley, SL; Kidwell, KM; Van Dyk, TR; Orkin, S; Odar Stough, C; Howarth, T; Goetz, AR; Xanthakos, SA; Bramlage, K; Mouzaki, M; et al. Journal of Pediatric Gastroenterology and Nutrition. 2022; 75:88-96.

Histologic Severity of Nonalcoholic Fatty Liver Disease Associates with Reduced Bone Mineral Density in Children. Khan, S; Kalkwarf, HJ; Hornung, L; Siegel, R; Arce-Clachar, AC; Sheridan, R; Ippisch, HM; Xanthakos, SA. Digestive Diseases and Sciences. 2022.

Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children With Non-Alcoholic Fatty Liver Disease. Yodoshi, T; Orkin, S; Trout, AT; Arce-Clachar, AC; Bramlage, K; Liu, C; Fei, L; Dillman, JR; Xanthakos, SA; Mouzaki, M. Journal of Pediatric Gastroenterology and Nutrition. 2022; 74:495-502.

Body composition measured by bioelectrical impedance analysis is a viable alternative to magnetic resonance imaging in children with nonalcoholic fatty liver disease. Orkin, S; Yodoshi, T; Romantic, E; Hitchcock, K; Arce-Clachar, AC; Bramlage, K; Sun, Q; Fei, L; Xanthakos, SA; Trout, AT; et al. Journal of Parenteral and Enteral Nutrition. 2022; 46:378-384.

Health-Related Social Needs Facing Youth with NonAlcoholic Fatty Liver Disease. Orkin, S; Yodoshi, T; Sun, Q; Fei, L; Meryum, S; Ley, S; Arce-Clachar, AC; Bramlage, K; Xanthakos, S; Kahn, R; et al. 2022; 3.

Alternative Etiologies of Liver Disease in Children With Suspected NAFLD. Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Xanthakos, SA; Valentino, PL; Mouzaki, M. Pediatrics. 2021; 147.

Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease. Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Xanthakos, SA; Mouzaki, M; Valentino, PL. Pediatric obesity. 2021; 16.

Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease?. Orkin, S; Yodoshi, T; Sun, Q; Fei, L; Meryum, S; Arce-Clachar, AC; Bramlage, K; Beck, AF; Mouzaki, M. Obesity Research. 2021; 29:171-176.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey